Skip to content

Synaptive Medical

Request correction

Toronto-based medical technology company building an integrated suite of precision imaging, navigation, and robotics for the AI-driven operating room.

Last updated September 27, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Synaptive Medical is a Canadian medical technology company headquartered in Toronto, Ontario. It develops and commercializes an integrated platform of surgical imaging, navigation, and robotics products intended to replace legacy microscopes and conventional MRI systems in the operating room. The company positions its technology around three claimed benefits: better patient outcomes through faster, safer and more precise surgery; lower system costs via reduced operating-room time and shorter hospital stays; and a technology foundation designed for AI-powered surgical care. The core of the offering is the Synaptive Integrated Suite, which the company describes as "Four Unique Products, One Transformational Platform." The suite spans diagnosis, review, treatment and management workflows. Its flagship components include EVRY MRI, a next-generation low-field 0.5T MRI system with best-in-class head imaging; Modus Plan, which performs automatic tractography segmentation to access patient-specific fiber bundles in seconds; Modus X, a robotic exoscope featuring advanced 4K 3D optics and fluorescence visualization; and Modus Nav, an enhanced navigation product. Together these products are marketed as a leap beyond analog surgical tools that the company argues cannot meet modern clinical demands. Synaptive states that its mission is to help clinicians see with greater precision and clarity, improving patient care everywhere. On its official website the company highlights a record of advancing transformative technologies, surpassing legacy systems, and setting a new standard for surgical excellence, citing patient procedures, countries of deployment, and issued patents across surgical robotics and optics, AI planning, navigation, and breakthrough MRI. The company is headquartered in Toronto and is privately held; it is not known to be listed on a public stock exchange. Its products are deployed internationally, and it operates in the medical device and surgical technology sector.

History

Synaptive Medical is a Toronto, Ontario-based medical technology company. Publicly available evidence identifies it as a company in Toronto, Canada, and its official website presents it as a developer of next-generation precision imaging, navigation, and robotics for surgery. The company has built its identity around challenging legacy surgical visualization and imaging tools — specifically conventional microscopes and traditional MRI systems — which it argues limit data, fragment workflows, prolong treatment, and contribute to poorer outcomes and clinician frustration. Rather than selling isolated devices, Synaptive has organized its portfolio into the Synaptive Integrated Suite, described as "Four Unique Products, One Transformational Platform." The suite is structured around the clinical workflow stages of diagnosis, review, treatment, and management. Its named products include EVRY MRI, a low-field 0.5T MRI system with a focus on head imaging; Modus Plan, which automates tractography segmentation to access patient-specific fiber bundles in seconds; Modus X, a robotic exoscope with 4K 3D optics and fluorescence visualization; and Modus Nav, an enhanced navigation offering. This combination of robotics, optics, AI planning, navigation, and MRI forms the technical basis the company cites for its claim of a "proven leap in technology." The company states its mission as helping clinicians see with greater precision and clarity to improve patient care everywhere. It markets three principal advantages: better outcomes through faster, safer, more precise surgeries; lower costs through reduced operating-room time and shorter hospital stays; and breakthrough technology designed for AI-powered surgical care. On its website it also cites a record of advancing transformative technologies, surpassing legacy systems, and setting a new standard for surgical excellence, referencing patient procedures, countries of deployment, and issued patents across surgical robotics and optics, AI planning, navigation, and breakthrough MRI. Synaptive is headquartered in Toronto and is privately held. Its products are deployed across multiple countries, giving it an international commercial footprint in the surgical technology and medical device sector. The available evidence does not specify a founding year, founders, ownership structure, or a public listing, and no dated corporate milestones are provided in the supplied sources.

Products and positioning

Next-generation precision imaging, navigation, and robotics for the AI-driven operating room, positioned as a replacement for legacy microscopes and MRIs.

  • Synaptive Integrated Suite

    An integrated platform described by the company as "Four Unique Products, One Transformational Platform," spanning diagnosis, review, treatment, and management.

  • EVRY MRI

    Next-generation, low-field 0.5T MRI with best-in-class head imaging.

  • Modus Plan

    Automatic tractography segmentation accessing patient-specific fiber bundles in seconds.

  • Modus X

    Robotic exoscope featuring advanced 4K 3D optics and fluorescence visualization.

  • Modus Nav

    Enhanced navigation product within the Synaptive Integrated Suite.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/synaptive-canada · Editorial policy · How profiles are compiled